🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to evaluate the safety and efficacy of lotep...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2014-09
Trial ID
NCT02208297
Treatments Being Tested
Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group fo...
Status
Completed
Location
Valeant Site 01
Start Date
2016-06
Trial ID
NCT02786901
Graft rejection has traditionally been one of the leading causes of cornea ...
Status
Completed
Location
Price Vision Group
Start Date
2013-03
Trial ID
NCT01853696
Treatments Being Tested
The objective of this study is to evaluate the safety and efficacy of lotep...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2013-12
Trial ID
NCT01996839
Treatments Being Tested
This study is being conducted to investigate the safety, comfort, and toler...
Status
Completed
Location
Bausch & Lomb Incorporated
Start Date
2013-05-17
Trial ID
NCT01817582
Treatments Being Tested
A pilot study to evaluate the impact of Lotemax® Gel (loteprednol etabonate...
Status
Withdrawn
Location
Cincinnati Eye Institute
Start Date
2014-01
Trial ID
NCT02028312
Treatments Being Tested